ChartMillAugust 15, 2026 at 6:31 AM NY2 Months Ago
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stands Out as a Quality Investing Candidate
Amphastar (AMPH) passes quality screen with 17.2% ROIC, 104% profit quality, and cheap valuation, but revenue growth lags.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill
